Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Harmony Biosciences Holdings Inc shares valued at $1,040,103 were sold by Dayno Jeffrey M. on Dec 12 ’25. At $40.11 per share, Dayno Jeffrey M. sold 25,933 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
Also, JEFFREY M DAYNO purchased 25,933 shares, netting a total of over 1,026,687 in proceeds.
Before that, Kapadia Sandip had sold 20,000 shares from its account. In a trade valued at $790,896, the CHIEF FINANCIAL OFFICER traded Harmony Biosciences Holdings Inc shares for $39.54 each. Upon closing the transaction, the insider’s holdings decreased to 20,000 shares, worth approximately $0.0.
As published in their initiating research note from Truist on July 21, 2025, Harmony Biosciences Holdings Inc [HRMY] has been a Buy and the price target has been revised to $48. Earlier on February 11, 2025, Deutsche Bank initiated its rating. Their recommendation was “a Buy” for HRMY stock.
Analyzing HRMY Stock Performance
On last trading session, Harmony Biosciences Holdings Inc [NASDAQ: HRMY] plunged -3.38% to $37.47. The stock’s lowest price that day was $37.12, but it reached a high of $39.0 in the same session. During the last five days, there has been a drop of approximately -5.35%. Over the course of the year, Harmony Biosciences Holdings Inc shares have jumped approximately 13.34%. Shares of the company reached a 52-week high of $40.93 on 01/21/25 and a 52-week low of $25.52 on 10/20/25.
Support And Resistance Levels for Harmony Biosciences Holdings Inc (HRMY)
According to the 24-hour chart, there is a support level at 36.73, which, if violated, would cause prices to drop to 35.98. In the upper region, resistance lies at 38.61. The next price resistance is at 39.74. RSI (Relative Strength Index) is 56.11 on the 14-day chart, showing neutral technical sentiment.
Is Harmony Biosciences Holdings Inc subject to short interest?
Stocks of Harmony Biosciences Holdings Inc saw a sharp rise in short interest on 2025-11-28 jumping by 0.33 million shares to 4.41 million. Data from Yahoo Finance shows that the short interest on 2025-10-31 was 4.08 million shares. A jump of 7.48% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 4.9 of the overall float, the days-to-cover ratio (short ratio) jumped to 4.9.
Which companies own the most shares of Harmony Biosciences Holdings Inc (HRMY)?
In terms of Harmony Biosciences Holdings Inc share price expectations, FactSet research, analysts set an average price target of 46 in the next 12 months, up nearly 18.62% from the previous closing price of $38.78. Analysts anticipate Harmony Biosciences Holdings Inc stock to reach 62 by 2025, with the lowest price target being 33. In spite of this, 6 analysts ranked Harmony Biosciences Holdings Inc stock as Buy at the end of 2025. On December 17, 2024, H.C. Wainwright assigned a price target of “a Buy” to the stock and initiated coverage with a $75.
